Mokan Wealth Management Inc. Abb Vie Inc. Transaction History
Mokan Wealth Management Inc.
- $179 Billion
- Q2 2025
A detailed history of Mokan Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mokan Wealth Management Inc. holds 18,297 shares of ABBV stock, worth $3.48 Million. This represents 1.9% of its overall portfolio holdings.
Number of Shares
18,297
Previous 15,061
21.49%
Holding current value
$3.48 Million
Previous $3.16 Billion
7.64%
% of portfolio
1.9%
Previous 1.9%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,252Shares Held
1.27BCall Options Held
16.8MPut Options Held
15.3M-
Vanguard Group Inc Valley Forge, PA174MShares$33.1 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.2 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.83 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $336B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...